Migraine is underdiagnosed and poorly treated
Businesses often don’t see a prevalence of migraine within their healthcare claims due to a lack of available care
1 in 6
Americans struggle with migraine1
20,000
The number of migraine patients for every 1 headache specialist in the US2
but your business is affected in lost time and productivity
19 days
average missed days annually due to migraine3
91%
say their work is affected by migraine4
Autoimmune costs are on the rise
Despite representing just 2-3% of members, a large percentage of total drug spend is tied to treating inflammatory autoimmune conditions5
Highly addressable
through a root cause approach, but typically managed through escalating prescriptions
In 2 years
almost 50% of patients newly diagnosed will advance to a costly biologic6
20%
of total drug spend is linked to treating autoimmune conditions7
Why AndHealth?
Low risk, high return
- AndHealth covers 100% of all program implementation and engagement fees so you can focus investment on your people
- You only pay Per Enrolled Employee Per Month (PEEPM)
- No deductibles or out-of-pocket costs for your employees
Patients engage with us
AndHealth patients interact with their care team 9 times per month, on average.
Our patients love us
92
Net Promoter Score (NPS)
Other company NPS references:
Starbucks 77, Cleveland Clinic 39, American Airlines 3
Disease management is a losing battle
Managing symptoms isn’t a long-term solution. When patients are able to achieve reversal and dramatically reduce their symptoms their need for additional healthcare decreases.
Addressing root causes through expert care
Sustaining results
The AndHealth approach to patient care
We are a digital healthcare provider taking a root cause, disease reversal approach to sustained remission. We help your employees by providing:
- Immediate virtual access
- Migraine and Autoimmune specialized physicians
- Expert medication management
- Root cause assessment and diagnosis
- 1-1 health coaching to support behavior change
Support your women and employees of color by improving access to care
85% of chronic migraine sufferers are women
and over half saw negative impacts on their careers due to migraine8
Due to an inequity in care,
BIPOC are 50% less likely to receive a migraine diagnosis
even though prevalence is consistent across backgrounds9
40% of women with autoimmune
feel like they aren’t taken seriously by their doctor10
Leading employers choose AndHealth
“The AndHealth team has been an incredible partner not only for me, but for our entire faculty, staff, and their dependents.
I’m amazed at the results – it is truly a lifesaver.”
Vanessa Wolfe
Human Resources Coordinator
“The AndHealth team has been an incredible partner not only for me, but for our entire faculty, staff, and their dependents.
I’m amazed at the results – it is truly a lifesaver.”
Vanessa Wolfe
Human Resources Coordinator
Employers and Brokers offer AndHealth as a covered benefit to help reduce their excess healthcare spending and improve their people’s quality of life.
- Burch R, Rizzoli P, Loder E. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies. Headache. 2018 Apr;58(4):496-505. doi: 10.1111/head.13281. Epub 2018 Mar 12. PMID: 29527677.
- https://americanheadachesociety.org/news/value-headache-specialist/
- Yucel, A.; Thach, A.; Kumar, S.; Loden, C.; Bensink, M. et al Estimating the Economic Burden of Migraine on US Employers The Am. J. Man. Care, December 2020, Volume 26, Issue 12
- https://pubmed.ncbi.nlm.nih.gov/18617829/
- https://www.primetherapeutics.com/research/dispel-the-mysteries-of-the-autoimmune-drug-category
- Wakely: Consulting Actuaries & Healthcare Specialists, Analysis of 20 million claims, 2022
- https://www.fiercehealthcare.com/payer/drugs-for-autoimmune-disorders-account-for-growing-part-pharmacy-spend-prime-therapeutics
- https://migraineatwork.org/news_articles/migraine-gender-gap-why-migraine-at-work-is-a-womens-health-issue/
- https://www.verywellmind.com/people-of-color-less-likely-to-receive-migraine-treatment-5189238
- https://www.latimes.com/opinion/op-ed/la-oe-dwass-gender-bias-medicine-20170726-story.html